HealthcarePsyence Biomedical to acquire drug developer ClairvoyantBy Helitra.com·September 7, 2024·1 min read Psyence Biomedical to acquire drug developer Clairvoyant Source: SeekingalphaADVERTISEMENT ADVERTISEMENTacquire Biomedical Clairvoyant developer drug Psyence Post navigation Previous storyAfya announces MEC decision on medical seats reconsiderationNext storyOrganon downgraded, Amneal upgraded as J.P. Morgan reviews specialty pharma
Fitness · HealthcareIf You Are on GLP-1 Drugs, You Must Lift Weights to Keep Your Muscle MassNovember 17, 2026For most of the past half century, a successful outcome meant a smaller number on the scale.That has changed. GLP-1 and dual-agonist medications…
Fitness · HealthcareWalking and Weightlifting May Miss a Bone-Health Benefit, Scientists FindNovember 17, 2026Walking and lifting weights are fitness staples, especially after 40. But a Semmelweis University analysis of 24 studies involving 1,238 adults suggests your…
Fitness · HealthcareImportant Screenings You Should Get When You Have PsoriasisNovember 16, 2026When you live with psoriasis, you need to pay attention to more than just the health of your skin. That’s because the condition…